ATE206049T1 - Verwendung eines inhibitors der no-synthetase als medikament zur reduktion des alkoholkonsums oder zur prävention eines exzessiven alkoholkonsums - Google Patents
Verwendung eines inhibitors der no-synthetase als medikament zur reduktion des alkoholkonsums oder zur prävention eines exzessiven alkoholkonsumsInfo
- Publication number
- ATE206049T1 ATE206049T1 AT95401781T AT95401781T ATE206049T1 AT E206049 T1 ATE206049 T1 AT E206049T1 AT 95401781 T AT95401781 T AT 95401781T AT 95401781 T AT95401781 T AT 95401781T AT E206049 T1 ATE206049 T1 AT E206049T1
- Authority
- AT
- Austria
- Prior art keywords
- alcohol consumption
- prevent excessive
- medication
- reduce
- synthetase inhibitor
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title abstract 5
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 102000003960 Ligases Human genes 0.000 abstract 2
- 108090000364 Ligases Proteins 0.000 abstract 2
- MRAUNPAHJZDYCK-BYPYZUCNSA-N L-nitroarginine Chemical compound OC(=O)[C@@H](N)CCCNC(=N)N[N+]([O-])=O MRAUNPAHJZDYCK-BYPYZUCNSA-N 0.000 abstract 1
- 230000003542 behavioural effect Effects 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9409445A FR2722986B1 (fr) | 1994-07-29 | 1994-07-29 | Utilisation d'un inhibiteur de la no-synthetase comme medicament destine a reduire la consommation d'alcool ou prevenir l'exces de consommation d'alcool |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE206049T1 true ATE206049T1 (de) | 2001-10-15 |
Family
ID=9465903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95401781T ATE206049T1 (de) | 1994-07-29 | 1995-07-27 | Verwendung eines inhibitors der no-synthetase als medikament zur reduktion des alkoholkonsums oder zur prävention eines exzessiven alkoholkonsums |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5639792A (de) |
| EP (1) | EP0702951B1 (de) |
| JP (1) | JPH0840889A (de) |
| AT (1) | ATE206049T1 (de) |
| DE (1) | DE69522881T2 (de) |
| DK (1) | DK0702951T3 (de) |
| ES (1) | ES2163480T3 (de) |
| FR (1) | FR2722986B1 (de) |
| PT (1) | PT702951E (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101256279B1 (ko) * | 2010-11-09 | 2013-04-18 | 대구한의대학교산학협력단 | 사우치논을 함유하는 약물중독 및 금단 증상의 예방 및 치료를 위한 조성물 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225440A (en) * | 1991-09-13 | 1993-07-06 | The United States Of America As Represented By The Department Of Health And Human Services | Attenuation of the opioid withdrawal syndrome by inhibitors of nitric oxide synthase |
-
1994
- 1994-07-29 FR FR9409445A patent/FR2722986B1/fr not_active Expired - Fee Related
-
1995
- 1995-07-27 EP EP95401781A patent/EP0702951B1/de not_active Expired - Lifetime
- 1995-07-27 DE DE69522881T patent/DE69522881T2/de not_active Expired - Fee Related
- 1995-07-27 ES ES95401781T patent/ES2163480T3/es not_active Expired - Lifetime
- 1995-07-27 DK DK95401781T patent/DK0702951T3/da active
- 1995-07-27 US US08/507,815 patent/US5639792A/en not_active Expired - Fee Related
- 1995-07-27 PT PT95401781T patent/PT702951E/pt unknown
- 1995-07-27 AT AT95401781T patent/ATE206049T1/de not_active IP Right Cessation
- 1995-07-31 JP JP7195146A patent/JPH0840889A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| PT702951E (pt) | 2002-02-28 |
| DK0702951T3 (da) | 2002-01-14 |
| EP0702951B1 (de) | 2001-09-26 |
| FR2722986A1 (fr) | 1996-02-02 |
| EP0702951A1 (de) | 1996-03-27 |
| FR2722986B1 (fr) | 1996-10-25 |
| ES2163480T3 (es) | 2002-02-01 |
| JPH0840889A (ja) | 1996-02-13 |
| US5639792A (en) | 1997-06-17 |
| DE69522881D1 (de) | 2001-10-31 |
| DE69522881T2 (de) | 2002-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI973492A (fi) | NO-syntaasin estäjät | |
| DE69815090D1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
| DK0610317T3 (da) | Inhibitorer af dipeptidyl-aminopeptidase type IV | |
| DE69619427T2 (de) | Zusammensetzung zur Behandlung und Pflege der Haare und der Kopfhaut enthaltend einen wässrig-alkoholischen oder alkoholischen Haferextrakt oder Hafermehl | |
| DE69939651D1 (de) | Behandlung hyperproliferativer erkrankungen | |
| NZ516562A (en) | Pyrimidine-2,4,6-trione metalloproteinase inhibitors | |
| DK0755249T3 (da) | Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom | |
| PT752813E (pt) | Inibidores de proteases de parasitas metazoarios | |
| WO2005014783A3 (en) | Reducing axon degeneration with proteasome inhibitors | |
| DE69034070T2 (de) | Racemisches Huperzin A | |
| MX9805290A (es) | Utilizacion de inhibidores de la actividad del acido retinoico para tratar las pieles sensibles y/o los daños agudos inducidos por las radiaciones ultravioleta. | |
| ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
| ATE173620T1 (de) | Verwendung eines antagonisten von tnf-alpha zur behandlung von hautrötungen neurogenen ursprungs | |
| DE69431162T2 (de) | Fenbendazolformulierungen | |
| PT1147088E (pt) | 6-arilfenantridinas com actividade inibitoria da pde-iv | |
| ATE206049T1 (de) | Verwendung eines inhibitors der no-synthetase als medikament zur reduktion des alkoholkonsums oder zur prävention eines exzessiven alkoholkonsums | |
| WO1996002240A3 (en) | Use of inhibitors of human s-cd23 | |
| DE60231896D1 (de) | Zusammensetzungen und verfahren zur erhöhung der compliance mit therapien unter verwendung von aldehyddehydrogenase-hemmern und zur behandlung von alkoholsmus | |
| DE69331546D1 (de) | Verwendung von cytochrome - p 450 - inhibitoren zur hemmung des stoffwechsels von stickstoffsubstituierten acridinen | |
| DK0828851T3 (da) | Tripeptidylpeptidaseinhibitorer | |
| WO2000064422A3 (en) | Novel treatment of neurotraumatic conditions with raf inhibitor | |
| FR2807645B1 (fr) | Utilisation d'inhibiteurs de l'alcool deshydrogenase dans le traitement cosmetique des matieres keratiniques | |
| ATE358673T1 (de) | Nf-kb-inhibitoren | |
| ATE374025T1 (de) | Verbindungen zur beseitigung und/oder linderung der anhedonie | |
| DE69906701D1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |